How valid is a prescription-based multimorbidity index (Rx-risk) in predicting mortality in the Outcomes and Multimorbidity In Type 2 diabetes (OMIT) study? A nation-wide registry-based cohort study from Norway.
Jannicke IglandRachel ForsterAnne Karen JenumRagnhild B StrandbergTore Julsrud BergJan Ivar RøssbergMarjolein Memelink IversenEsben Selmer Selmer BuhlPublished in: BMJ open (2024)
The Rx-risk index showed good discrimination and calibration in predicting mortality and thus presents a valid tool to assess multimorbidity among persons with type 2 diabetes.